Status:
COMPLETED
Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Patent Ductus Arteriosus
Eligibility:
All Genders
Up to 1 years
Brief Summary
BACKGROUND Patent ductus arteriosus (PDA) is a frequent clinical event in preterm infant. The cardiopulmonary functions of these preterm babies may be adversely affected by the patency of ductus arter...
Eligibility Criteria
Inclusion
- Clinical diagnosis of the patency of ductus arteriosus
Exclusion
- Congenital anomalies
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
End Date :
December 1 2002
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00162903
Start Date
January 1 2002
End Date
December 1 2002
Last Update
November 23 2005
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.